NCT06188637View on ClinicalTrials.gov

Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2027

Conditions
Ulcerative Colitis
Interventions
DRUG

Ozanimod Oral Capsule

open label ozanimod

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Geert D'Haens

OTHER